Moderna, Inc. MRNA
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · NASDAQ · United States · modernatx.com
Moderna, Inc. is a US biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, with commercial products including Spikevax (COVID-19 vaccine) and mRESVIA (RSV vaccine). The company has over 35 mRNA candidates in clinical development spanning infectious diseases, oncology, cardiovascular disease, and rare genetic disorders.
Key ratios
FreeCashFlowOnSale TTM -1.06
FreeCashFlowOnSale 2025 -1.06
FreeCashFlowOnSale 2024 -1.25
FreeCashFlowOnSale 2023 -0.56
NetIncomeMargin TTM -1.45
NetIncomeMargin 2025 -1.45
NetIncomeMargin 2024 -1.1
NetIncomeMargin 2023 -0.69
ReturnOnAssets TTM -0.15
ReturnOnAssets 2025 -0.15
ReturnOnAssets 2024 -0.15
ReturnOnAssets 2023 -0.12
ReturnOnEquity TTM -0.29
ReturnOnEquity 2025 -0.29
ReturnOnEquity 2024 -0.29
ReturnOnEquity 2023 -0.29
Recent news
Moderna Science Day Highlights Expanding Potential of mRNA Platform
2026-06-25 · StockTitan
Moderna flu vaccine wins unanimous support from FDA panel
2026-06-18 · BioPharma Dive